Early access
Sign in
Taking people in United StatesNo phase

Heart MRI scans to find signs of sarcoidosis and other heart conditions

Looks at heart MRI findings in adults with sarcoidosis having routine scans.

Key facts

Who runs it
Duke University
Where
Durham, United StatesSee the site
Trial code
Registry title
Prognostic Value of Clinical Cardiovascular MRI
Status
Recruiting
People taking part
27,000 people, planned
Started
Sept 2002
Expected to end
Jun 2032
Type of study
Observational
Record updated
16 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are already scheduled for a routine heart and blood vessel MRI scan (CMR) as part of their usual care.

Age
18 Years and older
Sex
All

Main reasons for not taking part

  • People who cannot have an MRI scan for medical reasons cannot join.

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Scheduled to undergo routine clinical CMR scan

Who cannot take part

  • Contraindication to MRI

Where in United States

  • Duke University Medical CenterDurham, United StatesContact: Han W Kim, MDTaking people

About the trial

What the trial wants to find out

The primary objective of this study is to identify findings on cardiovascular MR imaging (CMR) that are specific to various cardiac or vascular disorders in patients undergoing routine CMR scans.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prognostic Value of Clinical Cardiovascular MRI
Plain-language title
Heart MRI scans to find signs of sarcoidosis and other heart conditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
16 October 2026